These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 25224002)

  • 1. Delayed parasite clearance after treatment with dihydroartemisinin-piperaquine in Plasmodium falciparum malaria patients in central Vietnam.
    Thriemer K; Hong NV; Rosanas-Urgell A; Phuc BQ; Ha do M; Pockele E; Guetens P; Van NV; Duong TT; Amambua-Ngwa A; D'Alessandro U; Erhart A
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7049-55. PubMed ID: 25224002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of dihydroartemisinin/piperaquine and artesunate monotherapy for the treatment of uncomplicated Plasmodium falciparum malaria in Central Vietnam.
    Rovira-Vallbona E; Van Hong N; Kattenberg JH; Huan RM; Hien NTT; Ngoc NTH; Guetens P; Hieu NL; Mai TT; Duong NTT; Duong TT; Phuc BQ; Xa NX; Erhart A; Rosanas-Urgell A
    J Antimicrob Chemother; 2020 Aug; 75(8):2272-2281. PubMed ID: 32437557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
    Spring MD; Lin JT; Manning JE; Vanachayangkul P; Somethy S; Bun R; Se Y; Chann S; Ittiverakul M; Sia-ngam P; Kuntawunginn W; Arsanok M; Buathong N; Chaorattanakawee S; Gosi P; Ta-aksorn W; Chanarat N; Sundrakes S; Kong N; Heng TK; Nou S; Teja-isavadharm P; Pichyangkul S; Phann ST; Balasubramanian S; Juliano JJ; Meshnick SR; Chour CM; Prom S; Lanteri CA; Lon C; Saunders DL
    Lancet Infect Dis; 2015 Jun; 15(6):683-91. PubMed ID: 25877962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study.
    van der Pluijm RW; Imwong M; Chau NH; Hoa NT; Thuy-Nhien NT; Thanh NV; Jittamala P; Hanboonkunupakarn B; Chutasmit K; Saelow C; Runjarern R; Kaewmok W; Tripura R; Peto TJ; Yok S; Suon S; Sreng S; Mao S; Oun S; Yen S; Amaratunga C; Lek D; Huy R; Dhorda M; Chotivanich K; Ashley EA; Mukaka M; Waithira N; Cheah PY; Maude RJ; Amato R; Pearson RD; Gonçalves S; Jacob CG; Hamilton WL; Fairhurst RM; Tarning J; Winterberg M; Kwiatkowski DP; Pukrittayakamee S; Hien TT; Day NP; Miotto O; White NJ; Dondorp AM
    Lancet Infect Dis; 2019 Sep; 19(9):952-961. PubMed ID: 31345710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
    Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
    Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam.
    Hien TT; Thuy-Nhien NT; Phu NH; Boni MF; Thanh NV; Nha-Ca NT; Thai le H; Thai CQ; Toi PV; Thuan PD; Long le T; Dong le T; Merson L; Dolecek C; Stepniewska K; Ringwald P; White NJ; Farrar J; Wolbers M
    Malar J; 2012 Oct; 11():355. PubMed ID: 23101492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea.
    Tavul L; Hetzel MW; Teliki A; Walsh D; Kiniboro B; Rare L; Pulford J; Siba PM; Karl S; Makita L; Robinson L; Kattenberg JH; Laman M; Oswyn G; Mueller I
    Malar J; 2018 Oct; 17(1):350. PubMed ID: 30290825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance.
    Chaorattanakawee S; Saunders DL; Sea D; Chanarat N; Yingyuen K; Sundrakes S; Saingam P; Buathong N; Sriwichai S; Chann S; Se Y; Yom Y; Heng TK; Kong N; Kuntawunginn W; Tangthongchaiwiriya K; Jacob C; Takala-Harrison S; Plowe C; Lin JT; Chuor CM; Prom S; Tyner SD; Gosi P; Teja-Isavadharm P; Lon C; Lanteri CA
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4631-43. PubMed ID: 26014942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insight into k13-propeller gene polymorphism and ex vivo DHA-response profiles from Cameroonian isolates.
    Menard S; Tchoufack JN; Maffo CN; Nsango SE; Iriart X; Abate L; Tsapi MT; Awono-Ambéné PH; Abega Mekongo FA; Morlais I; Berry A
    Malar J; 2016 Nov; 15(1):572. PubMed ID: 27887614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam.
    Thanh NV; Thuy-Nhien N; Tuyen NT; Tong NT; Nha-Ca NT; Dong LT; Quang HH; Farrar J; Thwaites G; White NJ; Wolbers M; Hien TT
    Malar J; 2017 Jan; 16(1):27. PubMed ID: 28086775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parasite clearance rates in Upper Myanmar indicate a distinctive artemisinin resistance phenotype: a therapeutic efficacy study.
    Tun KM; Jeeyapant A; Imwong M; Thein M; Aung SS; Hlaing TM; Yuentrakul P; Promnarate C; Dhorda M; Woodrow CJ; Dondorp AM; Ashley EA; Smithuis FM; White NJ; Day NP
    Malar J; 2016 Mar; 15():185. PubMed ID: 27036739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study.
    Amaratunga C; Lim P; Suon S; Sreng S; Mao S; Sopha C; Sam B; Dek D; Try V; Amato R; Blessborn D; Song L; Tullo GS; Fay MP; Anderson JM; Tarning J; Fairhurst RM
    Lancet Infect Dis; 2016 Mar; 16(3):357-65. PubMed ID: 26774243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial.
    Tran TH; Dolecek C; Pham PM; Nguyen TD; Nguyen TT; Le HT; Dong TH; Tran TT; Stepniewska K; White NJ; Farrar J
    Lancet; 2004 Jan; 363(9402):18-22. PubMed ID: 14723988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam.
    Phuc BQ; Rasmussen C; Duong TT; Dong LT; Loi MA; Ménard D; Tarning J; Bustos D; Ringwald P; Galappaththy GL; Thieu NQ
    Emerg Infect Dis; 2017 Apr; 23(4):715-717. PubMed ID: 28322709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Single Mutation in K13 Predominates in Southern China and Is Associated With Delayed Clearance of Plasmodium falciparum Following Artemisinin Treatment.
    Huang F; Takala-Harrison S; Jacob CG; Liu H; Sun X; Yang H; Nyunt MM; Adams M; Zhou S; Xia Z; Ringwald P; Bustos MD; Tang L; Plowe CV
    J Infect Dis; 2015 Nov; 212(10):1629-35. PubMed ID: 25910630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyronaridine-Artesunate (Pyramax) for Treatment of Artemisinin- and Piperaquine-Resistant Plasmodium falciparum in the Central Highlands of Vietnam.
    Manh ND; Thanh NV; Quang HH; Van NTT; San NN; Phong NC; Birrell GW; Edstein MD; Edgel KA; Martin NJ; Chavchich M
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0027621. PubMed ID: 34570647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K13 Propeller Mutations in Plasmodium falciparum Populations in Regions of Malaria Endemicity in Vietnam from 2009 to 2016.
    Thuy-Nhien N; Tuyen NK; Tong NT; Vy NT; Thanh NV; Van HT; Huong-Thu P; Quang HH; Boni MF; Dolecek C; Farrar J; Thwaites GE; Miotto O; White NJ; Hien TT
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High therapeutic efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Somalia.
    Warsame M; Hassan AM; Hassan AH; Jibril AM; Khim N; Arale AM; Gomey AH; Nur ZS; Osman SM; Mohamed MS; Abdulrahman A; Yusuf FE; Amran JGH; Witkowski B; Ringwald P
    Malar J; 2019 Jul; 18(1):231. PubMed ID: 31296223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the asymptomatic reservoir and dihydroartemisinin-piperaquine effectiveness in a low transmission setting threatened by artemisinin resistant Plasmodium falciparum.
    Falq G; Van Den Bergh R; De Smet M; Etienne W; Nguon C; Rekol H; Imwong M; Dondorp A; Kindermans JM
    Malar J; 2016 Sep; 15(1):446. PubMed ID: 27585957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and tolerability of artemisinin-piperaquine (Artequick®) versus artesunate-amodiaquine (Coarsucam™) for the treatment of uncomplicated Plasmodium falciparum malaria in south-central Vietnam.
    Thanh NX; Trung TN; Phong NC; Quang HH; Dai B; Shanks GD; Chavchich M; Edstein MD
    Malar J; 2012 Jun; 11():217. PubMed ID: 22741618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.